Studies by Nechushtai et al. have demonstrated that the Fe-S cluster in CISD2 is central to human breast cancer proliferation by maintaining mitochondrial homeostasis, and could be developed as a fundamental chemotherapeutic target (15, 16). Here, CISD2 is linked to breast cancer.